90 related articles for article (PubMed ID: 26643423)
1. [Association between CCND1 G870A polymorphism and radiotherapy response in high-risk human papillomavirus-related cervical cancer].
Liang S; Zhang N; Huang R; Jiang J; Chen L; Lu Z; Li S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1205-9. PubMed ID: 26643423
[TBL] [Abstract][Full Text] [Related]
2. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
3. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
[TBL] [Abstract][Full Text] [Related]
4. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
[TBL] [Abstract][Full Text] [Related]
5. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
[TBL] [Abstract][Full Text] [Related]
6. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
11. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
12. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
[TBL] [Abstract][Full Text] [Related]
13. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer.
Ho-Pun-Cheung A; Assenat E; Thezenas S; Bibeau F; Rouanet P; Azria D; Cellier D; Grenier J; Ychou M; Senesse P; Lopez-Crapez E
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1094-101. PubMed ID: 17398034
[TBL] [Abstract][Full Text] [Related]
16. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
Yang SM; Shi YL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
[TBL] [Abstract][Full Text] [Related]
17. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
Cui J; Shen L; Wang Y
Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.
Satinder K; Chander SR; Pushpinder K; Indu G; Veena J
Mol Cell Biochem; 2008 Aug; 315(1-2):151-7. PubMed ID: 18548202
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]